人工智能去噪对神经内分泌肿瘤患者低剂量64Cu-DOTATATE PET病灶检测准确性的研究
本研究针对神经内分泌肿瘤患者,采用参数迁移Wasserstein生成对抗网络对模拟低剂量64Cu-DOTATATE PET图像(约为参考全剂量的25%,约48 MBq)进行去噪生成PETAI图像,并与全剂量PET100%(约191 MBq)比较。结果显示PETAI在图像质量与视觉相似性上优于低剂量图像,但医师病灶检测分析显示PETAI上假阳性和假阴性病灶比例较高,作者强调需要对AI算法进行临床验证。
要点
- PETAI与PET100%的Likert图像质量相似,33例中分别有32例和33例评为良好或优秀。
- PETAI病灶检测灵敏度为66%(78/118),假发现率为32%(37/115)。
- 37个假阳性病灶中62%(23/37)被评分为C1,提示为明确病灶。
核心结论
- 与PET25%相比,PETAI提高了与PET100%的视觉相似性,且PETAI与PET100%的Likert图像质量相似。
- 但医师进行的病灶检测分析显示PETAI上假阳性和假阴性病灶比例较高,作者强调需要对AI算法进行临床验证。
研究设计与样本
- 研究纳入38例神经内分泌肿瘤患者用于网络优化的训练集。
- 采用参数迁移Wasserstein生成对抗网络,对模拟低剂量64Cu-DOTATATE PET图像(对应注射活度的25%,约48 MBq,即PET25%)生成去噪图像PETAI,并与参考全剂量(约191 MBq,即PET100%)比较。
- 在每器官病灶不超过20个的患者子集(n=33)中,由两名读者评估Likert量表定义的图像质量并识别病灶可疑灶,以PET100%为参考进行1:1匹配比较。
主要发现
- PETAI/PET100%与PET25%/PET100%相比,PET强度相关拟合优度值为0.94对0.81,PSNR为58.1对53.0,SSIM为0.908对0.899,MSE为2.6对4.7。
- Likert量表定义的图像质量在PET100%和PETAI上分别有33例中的33例和33例中的32例评为良好或优秀。
- PET100%上检测到的病灶总数为118个,PETAI上为115个;PETAI上仅78个为真阳性,40个为假阴性,37个为假阳性。
- 检测灵敏度(TP/(TP+FN))为66%(78/118),假发现率(FP/(TP+FP))为32%(37/115)。
- 在62%(23/37)的病例中,假阳性病灶被评分为C1,提示为明确病灶。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出医师病灶检测分析显示PETAI上假阳性和假阴性病灶比例较高,强调需要对AI算法进行临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Frequent somatostatin receptor PET, for example, 64Cu-DOTATATE PET, is part of the diagnostic work-up of patients with neuroendocrine neoplasms (NENs), resulting in high accumulated radiation doses. Scan-related radiation exposure should be minimized in accordance with the as-low-as-reasonably achievable principle, for example, by reducing injected radiotracer activity. Previous investigations found that reducing 64Cu-DOTATATE activity to below 50 MBq results in inadequate image quality and lesion detection. We therefore investigated whether image quality and lesion detection of less than 50 MBq of 64Cu-DOTATATE PET could be restored using artificial intelligence (AI). Methods: We implemented a parameter-transferred Wasserstein generative adversarial network for patients with NENs on simulated low-dose 64Cu-DOTATATE PET images corresponding to 25% (PET25%), or about 48 MBq, of the injected activity of the reference full dose (PET100%), or about 191 MBq, to generate denoised PET images (PETAI). We included 38 patients in the training sets for network optimization. We analyzed PET intensity correlation, peak signal-to-noise ratio (PSNR), structural similarity index (SSIM), and mean-square error (MSE) of PETAI/PET100% versus PET25%/PET100% Two readers assessed Likert scale-defined image quality (1, very poor; 2, poor; 3, moderate; 4, good; 5, excellent) and identified lesion-suspicious foci on PETAI and PET100% in a subset of the patients with no more than 20 lesions per organ (n = 33) to allow comparison of all foci on a 1:1 basis. Detected foci were scored (C1, definite lesion; C0, lesion-suspicious focus) and matched with PET100% as the reference. True-positive (TP), false-positive (FP), and false-negative (FN) lesions were assessed. Results: For PETAI/PET100% versus PET25%/PET100%, PET intensity correlation had a goodness-of-fit value of 0.94 versus 0.81, PSNR was 58.1 versus 53.0, SSIM was 0.908 versus 0.899, and MSE was 2.6 versus 4.7. Likert scale-defined image quality was rated good or excellent in 33 of 33 and 32 of 33 patients on PET100% and PETAI, respectively. Total number of detected lesions was 118 on PET100% and 115 on PETAI Only 78 PETAI lesions were TP, 40 were FN, and 37 were FP, yielding detection sensitivity (TP/(TP+FN)) and a false discovery rate (FP/(TP+FP)) of 66% (78/118) and 32% (37/115), respectively. In 62% (23/37) of cases, the FP lesion was scored C1, suggesting a definite lesion. Conclusion: PETAI improved visual similarity with PET100% compared with PET25%, and PETAI and PET100% had similar Likert scale-defined image quality. However, lesion detection analysis performed by physicians showed high proportions of FP and FN lesions on PETAI, highlighting the need for clinical validation of AI algorithms.
引用
- Loft M, Ladefoged CN, Johnbeck CB, et al. An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose 64Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms. J Nucl Med. 2023. PMID: 37169532. doi:10.2967/jnumed.122.264826
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。